This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.

Benefits of Attending

Listen to talks on new predictive biomarker designs used to separate sensitivity levels in patients

Enhance your understanding of Bayesian survival models and how Bayesian belief networks can leverage operational risks in clinical trials

Join the discussion on the recognised need of real world evidence to enhance the flexibility of adaptive clinical trials and improve patient care

Explore the novel applications of adaptive designs in early and late phase clinical trials

Learn novel design strategies in Bio-marker driven adaptive designs from Multi Arms Multi